Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology

Approximately 6% of metastatic breast cancers arise de novo. While systemic therapy (ST) remains the treatment backbone as for patients with metachronous metastases, locoregional treatment (LRT) of the primary tumor remains a controversial method. The removal of the primary has an established role f...

Descripción completa

Detalles Bibliográficos
Autores principales: Merloni, Filippo, Palleschi, Michela, Gianni, Caterina, Casadei, Chiara, Curcio, Annalisa, Romeo, Antonino, Rocchi, Maddalena, Cima, Simona, Sirico, Marianna, Sarti, Samanta, Cecconetto, Lorenzo, Mariotti, Marita, Di Menna, Giandomenico, De Giorgi, Ugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923000/
https://www.ncbi.nlm.nih.gov/pubmed/36793604
http://dx.doi.org/10.3389/fonc.2023.1083297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923000/
https://www.ncbi.nlm.nih.gov/pubmed/36793604
http://dx.doi.org/10.3389/fonc.2023.1083297

Ejemplares similares